AGWCA
ABBV icon

Annis Gardner Whiting Capital Advisors’s AbbVie ABBV Stock Holding History

Annis Gardner Whiting Capital Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.72M Sell
6,840
-153
-2% -$32.9K 0.26% 60
2026
Q1 		$1.52M Buy
6,993
+899
+15% +$199K 0.24% 66
2025
Q4 		$1.39M Sell
6,094
-21
-0.3% -$4.78K 0.26% 67
2025
Q3 		$1.42M Buy
6,115
+1,185
+24% +$241K 0.29% 57
2025
Q2 		$915K Buy
4,930
+524
+12% +$97.4K 0.32% 65
2025
Q1 		$923K Sell
4,406
-139
-3% -$27K 0.39% 58
2024
Q4 		$808K Buy
4,545
+240
+6% +$44.1K 0.23% 81
2024
Q3 		$850K Sell
4,305
-586
-12% -$109K 0.24% 81
2024
Q2 		$839K Buy
4,891
+27
+0.6% +$4.47K 0.24% 81
2024
Q1 		$886K Buy
4,864
+622
+15% +$107K 0.32% 59
2023
Q4 		$657K Buy
4,242
+376
+10% +$54.8K 0.29% 68
2023
Q3 		$576K Buy
+3,866
New +$568K 0.31% 59

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Annis Gardner Whiting Capital Advisors's ABBV Position: Q2 2026 in Review

Annis Gardner Whiting Capital Advisors reduced its AbbVie (ABBV) stake by 2.2% in Q2 2026, selling an estimated $32.9K and leaving 6,840 shares worth $1.72M. The position accounts for 0.26% of the portfolio, ranked #60.

Annis Gardner Whiting Capital Advisors first reported a position in ABBV in Q3 2023 and has held it in 12 quarters since. 4,201 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Annis Gardner Whiting Capital Advisors held 6,840 shares of AbbVie worth $1.72M as of Q2 2026.
  • Annis Gardner Whiting Capital Advisors sold 153 AbbVie shares in Q2 2026, an estimated $32.9K.
  • AbbVie made up 0.26% of Annis Gardner Whiting Capital Advisors's portfolio in Q2 2026, its #60 holding.
  • Annis Gardner Whiting Capital Advisors first reported a position in AbbVie in Q3 2023 and has held it in 12 quarters since.
  • 4,201 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Annis Gardner Whiting Capital Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.